38.80
Schlusskurs vom Vortag:
$38.35
Offen:
$38.38
24-Stunden-Volumen:
516.01K
Relative Volume:
1.56
Marktkapitalisierung:
$1.22B
Einnahmen:
$566.77M
Nettoeinkommen (Verlust:
$48.16M
KGV:
32.61
EPS:
1.19
Netto-Cashflow:
$274.29M
1W Leistung:
-0.79%
1M Leistung:
+24.32%
6M Leistung:
+36.52%
1J Leistung:
+0.49%
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Firmenname
Collegium Pharmaceutical Inc
Sektor
Telefon
781-713-3699
Adresse
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Vergleichen Sie COLL mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
COLL
Collegium Pharmaceutical Inc
|
38.80 | 1.21B | 566.77M | 48.16M | 274.29M | 1.19 |
![]()
ZTS
Zoetis Inc
|
156.40 | 68.60B | 9.39B | 2.62B | 2.22B | 5.81 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.99 | 47.28B | 29.96B | 957.25M | 4.77B | 0.304 |
![]()
HLN
Haleon Plc Adr
|
9.80 | 43.41B | 14.26B | 1.98B | 2.47B | 0.4347 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.38 | 20.69B | 16.70B | -157.13M | 1.19B | -0.155 |
![]()
NBIX
Neurocrine Biosciences Inc
|
139.60 | 13.78B | 2.41B | 305.80M | 492.20M | 2.95 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-01-10 | Hochstufung | Needham | Hold → Buy |
2024-07-30 | Hochstufung | H.C. Wainwright | Neutral → Buy |
2024-06-07 | Hochstufung | Jefferies | Hold → Buy |
2024-05-10 | Herabstufung | Needham | Buy → Hold |
2024-05-10 | Herabstufung | Piper Sandler | Overweight → Neutral |
2024-01-04 | Herabstufung | Jefferies | Buy → Hold |
2023-08-25 | Bestätigt | Needham | Buy |
2023-05-02 | Fortgesetzt | Jefferies | Buy |
2022-08-08 | Herabstufung | H.C. Wainwright | Buy → Neutral |
2022-02-15 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
2021-08-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
2021-01-11 | Bestätigt | H.C. Wainwright | Buy |
2020-07-14 | Eingeleitet | BWS Financial | Sell |
2020-05-27 | Eingeleitet | Guggenheim | Neutral |
2020-02-19 | Fortgesetzt | Jefferies | Buy |
2019-10-30 | Bestätigt | Needham | Buy |
2019-05-03 | Fortgesetzt | H.C. Wainwright | Buy |
2019-04-12 | Fortgesetzt | Janney | Buy |
2019-03-20 | Eingeleitet | SunTrust | Hold |
2019-01-16 | Bestätigt | Needham | Buy |
2018-03-08 | Bestätigt | H.C. Wainwright | Buy |
2018-02-07 | Bestätigt | Needham | Buy |
2017-12-05 | Bestätigt | Needham | Buy |
2017-09-11 | Eingeleitet | H.C. Wainwright | Buy |
2017-05-11 | Bestätigt | Needham | Buy |
2016-09-13 | Eingeleitet | Gabelli & Co | Buy |
2015-06-01 | Eingeleitet | Jefferies | Buy |
2015-06-01 | Eingeleitet | Needham | Buy |
2015-06-01 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Collegium Pharmaceutical Inc Aktie (COLL) Neueste Nachrichten
Is Collegium Pharmaceutical Inc. forming a bottoming base2025 Volatility Report & Proven Capital Preservation Tips - Newser
How to build a dashboard for Collegium Pharmaceutical Inc. stockJuly 2025 Intraday Action & Daily Entry Point Alerts - Newser
Evaluating Collegium Pharmaceutical Inc. with trendline analysis2025 Key Lessons & Free Accurate Trade Setup Notifications - Newser
Will Collegium Pharmaceutical Inc. rebound enough to break evenFed Meeting & Weekly Momentum Picks - Newser
Chart based analysis of Collegium Pharmaceutical Inc. trendsJuly 2025 Opening Moves & Reliable Trade Execution Plans - Newser
What’s the recovery path for long term holders of Collegium Pharmaceutical Inc.GDP Growth & Pattern Based Trade Signal System - Newser
Has Collegium Pharmaceutical Inc. found a price floorJuly 2025 Trends & Safe Capital Growth Tips - Newser
Using data models to predict Collegium Pharmaceutical Inc. stock movementEarnings Beat & Weekly High Potential Stock Alerts - Newser
Developing predictive dashboards with Collegium Pharmaceutical Inc. dataGap Down & Daily Risk Controlled Trade Plans - Newser
Will a bounce in Collegium Pharmaceutical Inc. offer an exitEarnings Performance Report & Growth-Oriented Investment Plans - Newser
Technical analysis overview for Collegium Pharmaceutical Inc. stockEarnings Recap Report & Daily Profit Focused Screening - Newser
Will Collegium Pharmaceutical Inc. stock go up soonRate Cut & Consistent Growth Stock Picks - Newser
Is Collegium's (COLL) Real-World Pain Data Shaping Its Competitive Edge in Chronic Care? - simplywall.st
Collegium Pharmaceutical Inc. stock chart pattern explainedJuly 2025 Highlights & Weekly Breakout Opportunity Watchlist - Newser
Published on: 2025-08-30 07:31:16 - sundaytimes.kr
Collegium Pharmaceutical Inc. stock prediction for this weekAnalyst Upgrade & Capital Efficient Trading Techniques - Newser
Risk adjusted return profile for Collegium Pharmaceutical Inc. analyzed2025 Major Catalysts & Daily Stock Trend Reports - Newser
What is the earnings history of Collegium Pharmaceutical Inc.2025 Price Action Summary & Weekly Sector Rotation Insights - sundaytimes.kr
Collegium Pharmaceutical, Inc. (COLL) Highlights Real-World Evidence at PAINWeek 2025 - uk.finance.yahoo.com
Backtesting results for Collegium Pharmaceutical Inc. trading strategiesQuarterly Portfolio Review & Daily Momentum Trading Reports - Newser
Momentum Indicator Shows Bearish Divergence in Collegium Pharmaceutical Inc.IPO Watch & Target Return Focused Stock Picks - Newser
Analyzing Collegium Pharmaceutical Inc. with risk reward ratio chartsJuly 2025 Institutional & Long-Term Investment Growth Plans - Newser
Is Collegium Pharmaceutical Inc. stock poised for growthBond Market & Accurate Buy Signal Alerts - Newser
Collegium to Participate in Upcoming Investor Conferences - GlobeNewswire
Collegium Pharmaceutical Announces Management Participation in Investor Conferences. - AInvest
Leading Pharmaceutical Company Collegium Announces Triple Conference Lineup for September 2025 Schedule - Stock Titan
Finanzdaten der Collegium Pharmaceutical Inc-Aktie (COLL)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):